HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis

European Journal of Neurology

Volumn 17, Issue 3, 2010, Pages 506-509

  Pietilainen J ^a   Virtanen, J O ^a,b   Uotila, L ^b   Salonen, O ^b   Koskiniemi, M ^a   Farkkila M ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cerebrospinal fluid; Human herpesvirus 6; Multiple sclerosis; Primary infection

Indexed keywords

HUMAN HERPESVIRUS 6 ANTIBODY; IMMUNOGLOBULIN G; OLIGOCLONAL BAND; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TEMPORAL LOBE;

ACUTE DISEASE; ADULT; ANTIBODIES, VIRAL; BRAIN; CHRONIC DISEASE; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; ROSEOLOVIRUS INFECTIONS; TIME FACTORS; YOUNG ADULT;

EID: 77649157783     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02718.x     Document Type: Article

References (14)

1. Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev 1997 10 : 521 567.
2. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005 18 : 217 245.
3. Akhyani N, Berti R, Brennan MB, et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000 182 : 1321 1325.
4. Alvarez-Lafuente R, De Las Heras V, Bartolome M, et al. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol 2006 16 : 20 27.
5. Hall CB, Caserta MT, Schnabel KC, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998 26 : 132 137.
6. Virtanen JO, Färkkilä M, Multanen J, et al. Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications. J Neurovirol 2007 13 : 347 352.
7. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 2005 58 : 840 846.
8. Virtanen JO, Herrgard E, Valmari P, et al. Confirmed primary HHV-6 infection in children with suspected encephalitis. Neuropediatrics 2007 38 : 292 297.
9. Knox KK, Brewer JH, Henry JM, et al. Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis 2000 31 : 894 903.
10. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995 92 : 7440 7444.
11. Virtanen JO, Zabriskie JB, Siren V, et al. Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med Sci Monit 2005 11 : BR84 BR87.
12. Alvarez-Lafuente R, de las Heras V, Garcia-Montojo M, et al. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult Scler: Clin Lab Res 2007 13 : 578 583.
13. Soldan SS, Leist TP, Juhng KN, et al. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000 47 : 306 313.
14. Tejada-Simon MV, Zang YC, Hong J, et al. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003 53 : 189 197.